Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
Sophia C KamranYuzhen ZhouKeisuke OtaniMichael R DrummYukako OtaniShu-Lin WuChin-Lee WuAdam S FeldmanMatthew WszolekRichard J LeePhilip J SaylorJochen K LennerzEliezer Van AllenHenning WillersTheodore S HongYang LiuElai DavicioniEwan A GibbWilliam U ShipleyKent W MouwJason Alexander EfstathiouDavid T MiyamotoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Our data identify ERCC2 mutation as a candidate biomarker associated with sensitivity and long-term response to chemoradiation in MIBC. These findings warrant validation in independent cohorts.